AQR Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

AQR Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,093,582	Closed	-$46.1M	–	2414
2023 Q2	$46.1M	Sell	1,093,582 -1,352,342	-55%	-$54.7M	0.1%	235
2023 Q1	$86.8M	Buy	2,445,924 +289,651	+13%	+$10.5M	0.19%	123
2022 Q4	$78.4M	Buy	2,156,273 +1,289,817	+149%	+$51M	0.18%	137
2022 Q3	$40.9M	Buy	866,456 +62,918	+8%	+$4.06M	0.1%	248
2022 Q2	$57.6M	Buy	803,538 +373,351	+87%	+$27.3M	0.13%	197
2022 Q1	$34.8M	Buy	430,187 +102,192	+31%	+$8.64M	0.07%	347
2021 Q4	$33.7M	Sell	327,995 -80,907	-20%	-$7.77M	0.06%	340
2021 Q3	$35.8M	Buy	408,902 +93,867	+30%	+$8.5M	0.07%	325
2021 Q2	$28.1M	Buy	315,035 +59,890	+23%	+$5.06M	0.05%	409
2021 Q1	$19.4M	Buy	255,145 +42,797	+20%	+$3.23M	0.03%	515
2020 Q4	$14.2M	Sell	212,348 -340,925	-62%	-$21.3M	0.03%	525
2020 Q3	$29.4M	Buy	553,273 +79,481	+17%	+$4.73M	0.05%	384
2020 Q2	$27.3M	Buy	473,792 +251,740	+113%	+$13.5M	0.04%	414
2020 Q1	$8.75M	Buy	222,052 +68,718	+45%	+$4.02M	0.01%	654
2019 Q4	$9.12M	Buy	153,334 +13,319	+10%	+$716K	0.01%	781
2019 Q3	$7.45M	Sell	140,015 -11,642	-8%	-$597K	0.01%	841
2019 Q2	$7.57M	Buy	151,657 +85,214	+128%	+$3.97M	0.01%	844
2019 Q1	$3.43M	Buy	66,443 +54,320	+448%	+$2.63M	﹤0.01%	1131
2018 Q4	$477K	Buy	+12,123	New	+$563K	﹤0.01%	1794
2018 Q3	–	Sell	-4,710	Closed	-$221K	–	2347
2018 Q2	$221K	Sell	4,710 -1,464	-24%	-$60.6K	﹤0.01%	2198
2018 Q1	$219K	Sell	6,174 -129,143	-95%	-$5.06M	﹤0.01%	2118
2017 Q4	$5.9M	Sell	135,317 -536,656	-80%	-$25.1M	0.01%	965
2017 Q3	$35.1M	Buy	671,973 +551,432	+457%	+$30.7M	0.04%	467
2017 Q2	$7.05M	Buy	120,541 +32,409	+37%	+$1.68M	0.01%	903
2017 Q1	$4.04M	Sell	88,132 -8,518	-9%	-$424K	0.01%	1103
2016 Q4	$5.08M	Sell	96,650 -57,523	-37%	-$2.78M	0.01%	1039
2016 Q3	$6.87M	Buy	154,173 +12,653	+9%	+$549K	0.01%	886
2016 Q2	$5.4M	Buy	141,520 +46,448	+49%	+$2.04M	0.01%	884
2016 Q1	$3.92M	Buy	95,072 +82,019	+628%	+$3.38M	0.01%	960
2015 Q4	$633K	Buy	+13,053	New	+$581K	﹤0.01%	1773

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Capital Management's SYNH Position: Q3 2023 in Review

AQR Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,093,582 shares — an estimated $46.1M sold.

AQR Capital Management first reported a position in SYNH in Q4 2015 and held it in 30 quarters. The position peaked at $86.8M in Q1 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

AQR Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
AQR Capital Management sold 1,093,582 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $46.1M.
AQR Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 30 quarters.
AQR Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $86.8M in Q1 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.